Ampersand Capital Partners is a Boston-based private equity firm specializing in healthcare investments. With a focus on lower middle market companies in the United States, they typically invest in businesses with revenues ranging from $10 to $200 million. Ampersand's equity investments usually fall between $10 and $200 million per deal.

The firm boasts over 25 years of experience in healthcare investing and leverages its sector expertise and extensive operating networks to support entrepreneurs. Notable portfolio companies include AnaBios, Arranta Bio, and Vernal Biosciences. Ampersand's investment strategy spans various stages, from Series A to later rounds, demonstrating their commitment to long-term growth and value creation in the healthcare sector.